Weihua Li

机构：East China University of Science and Technology · ORCID：0009-0009-5838-1719

发表论文 17 篇 · 总被引 119 次 · h-index 6

代表论文

• ALK Rearrangement–Positive Pancreatic Cancer with Brain Metastasis Has Remarkable Response to ALK Inhibitors: A Case Report (2021 · Frontiers in Oncology · 被引 23)
• CD74/SLC34A2-ROS1 Fusion Variants Involving the Transmembrane Region Predict Poor Response to Crizotinib in NSCLC Independent of TP53 Mutations (2023 · Journal of Thoracic Oncology · 被引 20)
• Inguinal endometriosis: Ten case reports and review of literature (2021 · World Journal of Clinical Cases · 被引 17)
• Specific HER2 Exon 20 Gly776 Deletion-Insertions in Non-Small Cell Lung Cancer: Structural Analysis and Sensitivity to HER2-Targeted Tyrosine Kinase Inhibitors (2022 · Frontiers in Pharmacology · 被引 13)
• Efficacy and Safety of Neoadjuvant Chemotherapy Combined with Adjuvant Chemotherapy for Locally Advanced Colon Cancer: A Propensity Score-Matching Analysis (2022 · Medicina · 被引 10)
• Development and validation of a prognostic nomogram for bone metastasis from lung cancer: A large population-based study (2022 · Frontiers in Oncology · 被引 8)